Agilent Technologies, Inc. (NYSE:A) Position Reduced by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 1.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,089 shares of the medical research company’s stock after selling 262 shares during the period. Gulf International Bank UK Ltd’s holdings in Agilent Technologies were worth $3,101,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Flynn Zito Capital Management LLC raised its position in shares of Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock worth $251,000 after purchasing an additional 69 shares during the period. IFP Advisors Inc boosted its stake in Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 69 shares during the period. Brown Brothers Harriman & Co. boosted its position in shares of Agilent Technologies by 13.5% during the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after buying an additional 77 shares during the period. Rothschild Investment LLC boosted its position in Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after acquiring an additional 79 shares during the period. Finally, Rovin Capital UT ADV raised its stake in shares of Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares in the last quarter.

Analyst Ratings Changes

A has been the topic of a number of research analyst reports. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Bank of America dropped their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Robert W. Baird decreased their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $146.15.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $127.07 on Friday. The business’s 50 day moving average is $140.78 and its 200-day moving average is $139.20. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $36.25 billion, a PE ratio of 29.21, a PEG ratio of 3.64 and a beta of 1.07. Agilent Technologies, Inc. has a 1-year low of $124.16 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.58% and a net margin of 19.27%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. Agilent Technologies’s dividend payout ratio is 22.76%.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.